Hereditary precancerous polyps, also known as adenomatous polyposis, are a rare genetic condition that can lead to colon cancer if left untreated. These polyps are typically found in the colon and rectum and can cause symptoms such as rectal bleeding, abdominal pain, and changes in bowel habits.
Fortunately, a new treatment has been developed that can reduce the number of hereditary precancerous polyps and decrease the risk of colon cancer. In this article, we will discuss this new treatment and its benefits for those with hereditary precancerous polyps.
What Are Hereditary Precancerous Polyps?
Hereditary precancerous polyps are a genetic condition that causes the development of numerous polyps in the colon and rectum. These polyps are typically benign, but if left untreated, they can become cancerous.
The condition is caused by a mutation in the APC gene, which is responsible for controlling cell growth in the colon. This mutation causes cells to grow and divide uncontrollably, leading to the formation of polyps.
Hereditary precancerous polyps are inherited in an autosomal dominant pattern, meaning that a person only needs to inherit one copy of the mutated gene from one parent to develop the condition.
Current Treatment Options for Hereditary Precancerous Polyps
The most common treatment for hereditary precancerous polyps is polyp removal. This involves a colonoscopy, where a doctor uses a thin, flexible tube with a camera to view the inside of the colon and remove any polyps that are found.
While this treatment is effective in removing existing polyps, it does not prevent the development of new polyps. This means that individuals with hereditary precancerous polyps must undergo frequent colonoscopies to monitor and remove any new polyps that may develop.
The New Treatment: Targeted Therapy
Targeted therapy is a new treatment that has shown promising results in reducing the number of hereditary precancerous polyps and decreasing the risk of colon cancer.
This treatment involves the use of a medication that targets the specific mutation in the APC gene responsible for the development of polyps. By targeting this mutation, the medication can slow down or stop the growth of polyps in the colon and rectum.
Targeted therapy is administered through a pill that is taken daily. It is a non-invasive treatment option that does not require frequent colonoscopies, making it a more convenient and less invasive option for those with hereditary precancerous polyps.
Benefits of Targeted Therapy for Hereditary Precancerous Polyps
Targeted therapy has several benefits for individuals with hereditary precancerous polyps, including:
Reduced Risk of Colon Cancer
The most significant benefit of targeted therapy is its ability to reduce the risk of colon cancer. By targeting the specific mutation responsible for the development of polyps. This treatment can prevent the growth of new polyps and decrease the risk of colon cancer.
Non-Invasive Treatment Option
Unlike polyp removal, targeted therapy is a non-invasive treatment option that does not require frequent colonoscopies. This makes it a more convenient and less invasive option for those with hereditary precancerous polyps.
Improved Quality of Life
Individuals with hereditary precancerous polyps often have to undergo frequent colonoscopies, which can be uncomfortable and time-consuming. Targeted therapy eliminates the need for these procedures, improving the quality of life for those with this condition.
Who Is a Good Candidate for Targeted Therapy?
Targeted therapy is a suitable treatment option for individuals with hereditary precancerous polyps who have not yet developed colon cancer. It is also recommended for those who have had polyps removed in the past and are at high risk of developing new polyps.
Before starting targeted therapy, individuals will undergo genetic testing to confirm the presence of the APC gene mutation. This will help determine if targeted therapy is the right treatment option for them.
Side Effects of Targeted Therapy
As with any medication, targeted therapy may have some side effects. These can include:
- Diarrhea
- Nausea
- Fatigue
- Headaches
- Skin rash
These side effects are usually mild and can be managed with over-the-counter medications. If side effects become severe or persistent, it is essential to speak with a doctor.
Conclusion
Hereditary precancerous polyps are a rare genetic condition that can lead to colon cancer if left untreated. While polyp removal is the most common treatment option, it does not prevent the development of new polyps.
Targeted therapy is a new treatment that has shown promising results in reducing the number of hereditary precancerous polyps and decreasing the risk of colon cancer. This non-invasive treatment option has several benefits, including a reduced risk of colon cancer, improved quality of life, and convenience.
If you or a loved one has hereditary precancerous polyps, speak with a doctor about targeted therapy as a potential treatment option. With this new treatment, individuals with hereditary precancerous polyps can reduce their risk of colon cancer and improve their overall health and well-being.
